Associate Director - Competitive Analytics at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

(Not explicitly listed in the job description)

Responsibilities

Co-lead data integration and analytical frameworks: Develop and implement a structure that connects multiple data sources together to enable improved data quality, optimize analytical capabilities, and enable broad industry trend analyses to produce actionable competitive intelligence that informs portfolio strategy
Generate competitive value insights from across the industry: Develop and prosecute hypotheses for different strategies that competitors are leveraging to invest in and deliver their portfolio, develop capabilities, and maximize their value and productivity
Build and sustain valuable partnerships to drive strategy: Collaborate across the portfolio strategy team to support competitive insight projects with competitive analytics on an ongoing basis. Collaborate with key LRL and BU stakeholders for input on analytical conclusions and communications, incorporating feedback to develop new analyses and reporting capabilities
Leverage storytelling to communicate & influence: Tailor clear, concise, and compelling messages adapted to each audience. Communicate analyses to key customers beyond the portfolio strategy organization (e.g. figures, tables, and verbal conclusions to scientists, project teams and leadership). Demonstrate mastery of the subject matter, attention to detail and an ability to professionally defend the analyses and conclusions
Data management and process improvement: Partner with Decision Sciences and Analytics staff to monitor and communicate progress towards sustainability goals for our portfolio, including speed, success rates, and value creation
Deliver excellent portfolio review content, ensuring the accuracy of information with high attention to detail reported for pipeline progression and value analyses
Own the creation and sustainability of data analytics principles, integrating into competitive intelligence processes with a continuous improvement mindset
Serve as the functional SME/champions for information/data sharing platforms (e.g. Minerva, Penumbra, VITAL, etc.), improving the awareness and utilization

Skills

Competitive Analysis

Data Integration

Analytical Frameworks

R&D Strategy

Therapeutic Areas

Strategic Decision Making

Project Teams Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free